Why This Matters 

Wound dressings are more than supplies; they are therapeutic interventions that influence healing trajectory, infection risk, cost, and patient quality of life. In mobile wound care, clinicians must make product decisions in unpredictable environments where adherence, moisture control, and supply logistics vary widely. This article highlights why dressing selection in the field is a critical determinant of both clinical and operational success. 

The Scale of Chronic Wounds—and Why Dressings Matter 

An estimated 10.5 million Medicare beneficiaries are living with chronic wounds in the United States, generating billions in annual healthcare expenditures.¹ Globally, chronic wounds affect approximately 1%–2% of the population in developed countries at any given time.² 

The most common wound types managed in mobile practice—diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), and pressure injuries—are characterized by prolonged healing times and high recurrence rates. DFUs have lifetime incidence rates up to 34% among individuals with diabetes.³ VLUs account for nearly 70% of all lower-extremity ulcers and frequently persist for months to years.⁴ Pressure injuries affect approximately 2.5 million patients annually in the United States across care settings.⁵ 

Across these wound types, dressing performance influences moisture balance, bioburden control, exudate management, and protection from external contamination. Suboptimal dressing selection is associated with maceration, delayed healing, periwound breakdown, and increased infection risk.⁶ 

For wound professionals practicing in the field, dressing choice is not simply a technical decision—it is a primary modifiable factor affecting healing outcomes. 

Moisture Balance and Healing Trajectory 

Moist wound healing has been the standard of care for decades, yet achieving optimal moisture balance remains challenging. Excess exudate can lead to maceration and protease imbalance, while insufficient moisture can impair epithelial migration and granulation tissue formation.⁶ 

Chronic wounds often demonstrate elevated levels of inflammatory cytokines and matrix metalloproteinases, which degrade extracellular matrix components and delay healing.⁷ Dressings that inadequately manage exudate may exacerbate this biochemical environment. 

In mobile practice, clinicians must anticipate how dressings will perform between visits—often 3 to 7 days apart—without the controlled variables of clinic-based observation. Real-world factors such as ambient temperature, patient mobility, edema fluctuations, and caregiver technique influence wear time and effectiveness. 

Given that median healing times for VLUs can exceed 12 weeks and DFUs frequently persist beyond 20 weeks, cumulative dressing performance over time significantly affects total healing duration and resource utilization.^3,4 

Infection Risk and Antimicrobial Stewardship 

Infection complicates more than half of DFUs and substantially increases the risk of hospitalization and amputation.³ Chronic wounds frequently harbor polymicrobial biofilms, which are associated with delayed healing and antibiotic tolerance.⁸ 

Topical antimicrobial dressings—such as those containing agents like silver, iodine, or polyhexamethylene biguanide—are widely used, yet their selection must align with clinical indications and antimicrobial stewardship principles.⁹ Overuse or inappropriate use may increase costs without improving outcomes. 

The Centers for Disease Control and Prevention (CDC) reports more than 2.8 million antimicrobial-resistant infections annually in the United States.¹⁰ Responsible dressing selection, particularly in mobile settings where systemic antibiotic oversight may vary, contributes to broader resistance mitigation efforts. 

Mobile clinicians have a distinct vantage point to observe environmental contamination risks, hygiene practices, and adherence patterns—all of which influence infection prevention and dressing durability outside controlled facilities. 

Cost, Standardization, and Operational Impact 

Chronic wound care imposes substantial financial burden. Medicare expenditures for wound management exceed $28 billion annually.1 Dressing costs represent a significant component of outpatient wound care spending, particularly when advanced products are used over prolonged periods. 

Cost-effectiveness analyses emphasize that product selection should account not only for unit price but also for wear time, frequency of changes, complication rates, and impact on healing duration.¹¹ Inconsistent product selection across providers may increase supply waste, documentation variability, and billing complexity. 

For mobile practices, supply chain efficiency is critical. Clinicians must transport products, anticipate patient-specific needs, and adapt to reimbursement constraints. Standardized formularies and evidence-based selection frameworks can reduce variability while supporting quality metrics and compliance. 

As healthcare shifts toward value-based reimbursement, preventable complications—including infection and wound deterioration—carry financial penalties. Dressing decisions therefore have implications beyond the wound bed, affecting overall care costs and performance benchmarks. 

Why This Conversation Is Essential Now 

The prevalence of diabetes, vascular disease, and an aging population ensures that chronic wounds will remain a dominant clinical challenge.^3,4 Simultaneously, more care is delivered in the home, where environmental variability complicates traditional dressing protocols. 

Mobile wound clinicians operate at the intersection of clinical judgment and real-world unpredictability. Understanding how dressing performance translates outside clinic walls—and how standardization, cost-awareness, and infection prevention intersect—is central to optimizing outcomes. In an era defined by rising wound prevalence, antimicrobial resistance, and reimbursement scrutiny, dressing decisions on the go are not routine—they are strategic. 

References